drug-related AEs were reported by 58.6% of those receiving survodutide, with half of these participants reporting drug-related GI disorders
Yosimichi G, Nakanishi T, Nishida T, et al
In such cases, close monitoring of the Schwannoma is a treatment option Plexiform Schwannoma and Cellular Schwannoma are difficult to completely remove due to the fact that they may be closely involved with a nerve Additional and Relevant Useful Information for Schwannoma: A differential diagnosis may have to be undertaken to eliminate other tumors such as: Neurofibroma Leiomyosarcoma Gastrointestinal stromal tumor (GIST) Malignant peripheral nerve sheath tumor (MPNST) Please visit our Cancer & Benign Tumor Health Center for more physician-approved health information:
one sample was classified as mixed 1a + 1b subtypes by GT Plus ), 11/11 for subtype 1b (100%), and 1/6 for those detected as mixed 1a + 1b subtypes (16.7%
Comprehensive labs including testosterone, LH, FSH, estradiol, hematocrit, PSA, and a metabolic panel are required
